For Healthcare

Let's change the way the world sees and treats mental health.

Discover our Screening and Monitoring Solutions

The State of Mental Health Care Today

Today, mental health assessments rely on patient reporting of symptoms which are by nature, subjective. Such subjectivity often impacts symptom reporting, even when an individual is responding to treatment. Medibio provides access to objective biometrics to help make more accurate diagnoses and ensure optimal care through patient monitoring decision support.

Objective measures can play a critical role in:
.01

Onset detection

.02

Management of symptoms over time

.03

Monitoring of treatment response & compliance

.04

Patient self-management

Major studies

Versus 33-50% – Diagnostic accuracy in the Primary Care Setting1

Depression

Retrospective Study, 889 patients
November 2016, Ottawa University

Depression

Retrospective Study, 26 patients
December 2016, Johns Hopkins Medicine

Depression, Anxiety Disorder, Schizophrenia

Various Studies, Peer Reviewed

Sleep Staging using ECG Data

7500 patients
June 2016, John Hopkins Medicine

Depression

220 patients
July 2016, Multiple Sites

PTSD

48 patients
May 2017, Emory University

(1) Depression in Primary Care Vol 1: U.S. Department of Health

** Accuracy refers to the level of agreement between the results of the Medibio algorithms under evaluation as compared to the results of standard
assessments such as the Mini International Neuropsychiatric Interview, Hamilton Rating Scale for Depression or Beck Depression Inventory.

Physiology meets data science

Our approach exploits features of cardiovascular physiology influenced directly by the autonomic nervous system and susceptible to perturbation during sleep, as a source of biomarkers that correlate with onset and existence of mental dysfunction.

Our data science approach focuses on using artificial intelligence to identify mental illness phenotypes and potential physiological markers, so we can predict dysregulation of the autonomic nervous system and future recurrent episodes.

Normal
Depression
Anxiety
Coming Q4 2018

Mental Health Monitoring

Our product is designed to improve specificity of diagnosis, avoid hospitalization, reduce readmission, increase clinical efficiency and decrease time to intervention. Additionally, the platform will aggregate data from multiple sources for use with an internal data analytics platform.

Customizable Features include:
  • HIPAA-compliant
  • Administrative management of platform users
  • Longitudinal view of data points – heart rate, sleep, mood tracking
  • Engagement with mental insight scoring and utilization of platform features for wellness management
  • Data analytics
  • Alerts and Notifications
  • Depression episode integration (Index data)
  • EHR integration
  • Personalized reports

Have a representative contact me to learn more.             

Contact us to learn more about our patient screening, monitoring and management solutions coming late 2018.